There are 2789 resources available
392P - Integrating fragmentomic features for non-invasive early detection of colorectal advanced adenoma and adenocarcinoma
Presenter: Junjie Peng
Session: ePoster Display
433P - Durvalumab and tremelimumab in combination with FOLFOX in patients with previously untreated RAS-mutated metastatic colorectal cancer: First results of efficacy at one year for phase II MEDITREME trial
Presenter: Jean-David Fumet
Session: ePoster Display
436P - Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC)
Presenter: Omar Saavedra Santa Gadea
Session: ePoster Display
437P - Quality of life (QoL) in patients (pts) with microsatellite instability (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC) treated with nivolumab (NIVO) alone or in combination with ipilimumab (IPI): CheckMate 142
Presenter: Eric Van Cutsem
Session: ePoster Display
400P - Baseline expression of RAD23B protein in circulating tumor cells correlates with complete pathological response of neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Presenter: Virgilio E Silva
Session: ePoster Display
401P - Translation of the IDEA trial into clinical practice: Evaluation of implementation of a new guideline
Presenter: Karlijn Rooijen van
Session: ePoster Display
402P - Chemoradiation versus less intensive treatments in stage I squamous cell carcinoma of the anal canal (SCCA)
Presenter: Rachel Riechelmann
Session: ePoster Display
404P - The clinical value of C-reactive protein and its association with tumour sidedness in patients undergoing curative surgery for colorectal cancer: A ScotScan collaborative study
Presenter: Anniken Joerlo Fuglestad
Session: ePoster Display